Drug Database
Back to search

Poland· PL-100417435

Yasmin

A progestogens and estrogens, fixed combinations product containing ethinylestradiolum + drospirenonum, registered in Poland by Pharmapoint SA. The same ATC class is registered in 3 of our 19 countries.

ATC G03AA

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedYasminATCG03AAREGISTER NO.PL-100417435PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ethinylestradiolum + drospirenonumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ethinylestradiolum + drospirenonum is registered in 3 of 19 countries.

Countries holding a registration under ATC G03AA (progestogens and estrogens, fixed combinations), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose
Search ethinylestradiolum + drospirenonum products by name

Ethinylestradiolum + drospirenonum · ATC G03AA

3 / 19 countries

  • Belgiumprice
  • Ireland
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ethinylestradiolum + Drospirenonum
Manufacturer
Pharmapoint SA
Country
Poland (PL)
ATC code
G03AA
ATC class
Progestogens and estrogens, fixed combinations
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991395933

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ethinylestradiolum + drospirenonum in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ethinylestradiolum + drospirenonum products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Aliane, Danselle 21
  • Belgium · Annaïs 20, Annaïs 30 Ceres Pharma
  • Bulgaria · Жанги, Крипинео
  • Cyprus · Yasmin, Yasminelle
  • Czechia · Abella, Cris
  • Germany · Aida, Drospifem 20
  • Denmark · Asubtela, Etindros 21
  • Estonia · Jangee, Madeleine
  • Spain · Aidra, Aidraelle
  • Finland · Diza, Midiana
  • France · Drospibel, Drospirenone/Ethinylestradiol
  • United Kingdom (Northern Ireland) · Dretine, Ellanite
  • Greece · Estrofix, Yasmin
  • Croatia · Crypineo, Rosanne
  • Hungary · Altforalle, Aranka
  • Ireland · Dretine, Dretinelle
  • Iceland · Asubtela, Yasmin
  • Italy · Calindir, Cris
  • Lithuania · Edrocont, Etindros
  • Luxembourg · Annaïs 20 Ceres Pharma, Annaïs 30 Ceres Pharma
  • Latvia · Etindros, Midiana
  • Malta · Edrocont, Freedonel
  • Netherlands · Baradly, Belanette
  • Norway · Calima, Diza
  • Portugal · Aranka, Arankelle
  • Romania · Yasmin
  • Sweden · Diza, Maitalon
  • Slovenia · Crypineo, Daylla
  • Slovakia · Daylla, Emie

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d1eb1941-edb7-43d7-b7e2-6f379e3587ef
GET /v1/drugs/d1eb1941-edb7-43d7-b7e2-6f379e3587ef?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "0,03 mg + 3 mg",
  "packaging": "05909991395933 ¦ Rp ¦ 131494\n21 tabl.",
  "substance": "Ethinylestradiolum 0.03 mg + Drospirenonum 3 mg",
  "common_name": "Ethinylestradiolum + Drospirenonum",
  "pl_product_id": "100417435",
  "pozwolenie_nr": "87/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2024-03-06"
}
API referenceMCP serverPlans

See everything about ethinylestradiolum + drospirenonum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console